Search News Archives
Special Offers and Promotions
Conferences | Events
CD Genomics Releases Kits and Reagents for Coronavirus Research to Aid in COVID-19 Response
New CD Viral DNA & RNA Kit for coronavirus detection
COVID-19 is a serious global infectious disease outbreak with nearly 6,800,000 cases and around 397,000 deaths worldwide. As a professional biotech company, CD Genomics' Kits and reagents are based on some of the most powerful platforms. During this pandemic, it releases Kits and reagents products for coronavirus detection and research to help fight against the disease.
The COVID-19 coronavirus disease is an infectious disease caused by severe acute respiratory syndrome coronavirus 2. Common symptoms include fever, cough, and shortness of breath. Other symptoms may include muscle pain, sputum production, diarrhea, sore throat, loss of smell, and abdominal pain. The World Health Organization officially announced the outbreak of COVID-19 as a global pandemic in March this year.
“As long as COVID-19 threatens any country, the entire world is at risk and therefore every effort must be made to avoid mistakes of the past by ensuring protection is extended to everyone on earth, not just those with the means to afford it. CD Genomics provides CD Viral DNA & RNA Kit for coronavirus detection to help the detection of this disease. We have served the pharmaceutical and biotechnology industries for years and in such hard times will still be fully supportive to our clients worldwide.” commented vice president of CD Genomics.
The Virus Collection Kit is designed for collection, transportation and short-time storage of total DNA/RNA in clinical specimens such as saliva, blood, serum, stool and body fluid, etc. The preservative will lyse the organisms and inactivate the cells, bacteria and viruses. The stored samples can be used in subsequent clinical experiments such as DNA/RNA extraction, PCR testing or sequencing. The kit is ideal for collecting specimens for coronavirus identification and downstream studies.
The features of Kits and reagents at CD Genomics
1. Absorbent material increases buccal cell concentrations to give high quality results
2. Stringent quality control
3. Packaged in a clean-room environment
4. Gamma irradiation ensures sterility
5. Tough, break-resistant tubes with secure, color-coded screw caps prevent leaking and exposure to infectious agents
6. Sampling can be done at home or other places without any special training
7. Highly suited for automation
8. Ideal for Coronavirus identification
Early protection, early detection, early diagnosis, and early isolation are the key methods to prevent and control an infectious disease like the COVID-19. The detection of SARS-CoV-2 is very important for patient diagnosis. CD Genomics has been proven the high reliability of its products and is able to offer remarkable Kits and reagents for coronavirus detection.
“As our customers, it is very important for us to protect your normal business. Therefore, we are working hard to avoid business interruption, and at the same time make every effort to take action to prevent the spread of coronavirus.” said Dr. Charlie.
About CD Genomics
CD Genomics has been an internationally leading provider of microbial sampling products, microbial testing services, microbial genomics services, and integrated bioinformatics services for hospitals, food, diagnostics, pharma, agriculture, biotechnology, and research institutes.